Aristotle Atlantic Partners »

Immunome shares owned by Aristotle Atlantic Partners

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Aristotle Atlantic Partners from 13F filings

Historical chart of Aristotle Atlantic Partners investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Aristotle Atlantic Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Aristotle Atlantic Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 125k 21.87

More positions owned by Aristotle Atlantic Partners

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Ametek (AME)
Visa Com Cl A (V)
Darling International (DAR)
Exxon Mobil Corporation (XOM)
Trane Technologies SHS (TT)
Guardant Health (GH)

View all positions for Aristotle Atlantic Partners

Top funds holding Immunome

FMR
BlackRock
Redmile Group
State Street Corporation
PRIMECAP Management Company
Wellington Management Company
Vanguard Capital Management
Driehaus Capital Management
Enavate Sciences GP
Morgan Stanley
Geode Capital Management
Leucadia National Corporation
Silverarc Capital Management
Sofinnova Ventures
Woodline Partners

View all funds holding Immunome